APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exosome Isolation Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Exosome Isolation Service Market Analysis and Forecast 2026-2032

30 January 2026210 pages

Choose your research edition.

Industry ResearchExosome Isolation Service Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Exosome Isolation Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Exosome Isolation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exosome Isolation Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Exosome Isolation Service Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Exosome Isolation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Exosome Isolation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Exosome Isolation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Exosome Isolation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Exosome Isolation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Exosome Isolation Service include Codiak Biosciences, Aethlon Medical, NanoSomix, Aruna Bio, Creative Biostructure, AMSBIO, Everzom, System Biosciences and Creative Biolabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Exosome Isolation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Exosome Isolation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Exosome Isolation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Exosome Isolation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Exosome Isolation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Exosome Isolation Service revenue, projected growth trends, production technology, application and end-user industry.

Exosome Isolation Service Segment by Company

Codiak Biosciences

Aethlon Medical

NanoSomix

Aruna Bio

Creative Biostructure

AMSBIO

Everzom

System Biosciences

Creative Biolabs

Frontage Labs

Lonza

Capital Biosciences

Miltenyi Biotec

Novus Biologicals

Clara Biotech

Immunostep

ExosomeDx

Irvine Scientific

Beckman Coulter

Stratech

QIAGEN

Lifeasible

Exosome Isolation Service Segment by Type

Ultracentrifugation

Immunomagnetic Bead Method

Size Exclusion Chromatography

Exosome Isolation Service Segment by Application

Early Cancer Screening

Neurological Disease Diagnosis

Drug Delivery System Development

Regenerative Medicine

Other

Exosome Isolation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Isolation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exosome Isolation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Isolation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Exosome Isolation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Exosome Isolation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Isolation Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Exosome Isolation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ultracentrifugation Major Player Table 3. Immunomagnetic Bead Method Major Player Table 4. Size Exclusion Chromatography Major Player Table 5. Global Exosome Isolation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Early Cancer Screening Major Player Table 7. Neurological Disease Diagnosis Major Player Table 8. Drug Delivery System Development Major Player Table 9. Regenerative Medicine Major Player Table 10. Other Major Player Table 11. Exosome Isolation Service Industry Trends Table 12. Exosome Isolation Service Industry Drivers Table 13. Exosome Isolation Service Industry Opportunities and Challenges Table 14. Exosome Isolation Service Industry Restraints Table 15. Global Exosome Isolation Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Exosome Isolation Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Exosome Isolation Service Market Share by Region (2021-2026) Table 18. Global Exosome Isolation Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Exosome Isolation Service Market Share by Region (2027-2032) Table 20. Global Exosome Isolation Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Exosome Isolation Service Revenue Market Share by Players (2021-2026) Table 22. Global Exosome Isolation Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Exosome Isolation Service Key Players Headquarters & Area Served Table 24. Global Exosome Isolation Service Players, Product Type & Application Table 25. Global Exosome Isolation Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Exosome Isolation Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Exosome Isolation Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Exosome Isolation Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Exosome Isolation Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Exosome Isolation Service Revenue Market Share by Type (2021-2026) Table 32. Global Exosome Isolation Service Revenue Market Share by Type (2027-2032) Table 33. Global Exosome Isolation Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Exosome Isolation Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Exosome Isolation Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Exosome Isolation Service Revenue Market Share by Application (2021-2026) Table 37. Global Exosome Isolation Service Revenue Market Share by Application (2027-2032) Table 38. Codiak Biosciences Company Information Table 39. Codiak Biosciences Business Overview Table 40. Codiak Biosciences Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Codiak Biosciences Exosome Isolation Service Product Portfolio Table 42. Codiak Biosciences Recent Development Table 43. Aethlon Medical Company Information Table 44. Aethlon Medical Business Overview Table 45. Aethlon Medical Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Aethlon Medical Exosome Isolation Service Product Portfolio Table 47. Aethlon Medical Recent Development Table 48. NanoSomix Company Information Table 49. NanoSomix Business Overview Table 50. NanoSomix Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. NanoSomix Exosome Isolation Service Product Portfolio Table 52. NanoSomix Recent Development Table 53. Aruna Bio Company Information Table 54. Aruna Bio Business Overview Table 55. Aruna Bio Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Aruna Bio Exosome Isolation Service Product Portfolio Table 57. Aruna Bio Recent Development Table 58. Creative Biostructure Company Information Table 59. Creative Biostructure Business Overview Table 60. Creative Biostructure Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Creative Biostructure Exosome Isolation Service Product Portfolio Table 62. Creative Biostructure Recent Development Table 63. AMSBIO Company Information Table 64. AMSBIO Business Overview Table 65. AMSBIO Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. AMSBIO Exosome Isolation Service Product Portfolio Table 67. AMSBIO Recent Development Table 68. Everzom Company Information Table 69. Everzom Business Overview Table 70. Everzom Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Everzom Exosome Isolation Service Product Portfolio Table 72. Everzom Recent Development Table 73. System Biosciences Company Information Table 74. System Biosciences Business Overview Table 75. System Biosciences Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. System Biosciences Exosome Isolation Service Product Portfolio Table 77. System Biosciences Recent Development Table 78. Creative Biolabs Company Information Table 79. Creative Biolabs Business Overview Table 80. Creative Biolabs Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Creative Biolabs Exosome Isolation Service Product Portfolio Table 82. Creative Biolabs Recent Development Table 83. Frontage Labs Company Information Table 84. Frontage Labs Business Overview Table 85. Frontage Labs Exosome Isolation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Frontage Labs Exosome Isolation Service Product Portfolio Table 87. Frontage Labs Recent Development Table 88. Lonza Company Information Table 89. Lonza Business Overview Table 90. Lonza Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Lonza Exosome Isolation Service Product Portfolio Table 92. Lonza Recent Development Table 93. Capital Biosciences Company Information Table 94. Capital Biosciences Business Overview Table 95. Capital Biosciences Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Capital Biosciences Exosome Isolation Service Product Portfolio Table 97. Capital Biosciences Recent Development Table 98. Miltenyi Biotec Company Information Table 99. Miltenyi Biotec Business Overview Table 100. Miltenyi Biotec Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Miltenyi Biotec Exosome Isolation Service Product Portfolio Table 102. Miltenyi Biotec Recent Development Table 103. Novus Biologicals Company Information Table 104. Novus Biologicals Business Overview Table 105. Novus Biologicals Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Novus Biologicals Exosome Isolation Service Product Portfolio Table 107. Novus Biologicals Recent Development Table 108. Clara Biotech Company Information Table 109. Clara Biotech Business Overview Table 110. Clara Biotech Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Clara Biotech Exosome Isolation Service Product Portfolio Table 112. Clara Biotech Recent Development Table 113. Immunostep Company Information Table 114. Immunostep Business Overview Table 115. Immunostep Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Immunostep Exosome Isolation Service Product Portfolio Table 117. Immunostep Recent Development Table 118. ExosomeDx Company Information Table 119. ExosomeDx Business Overview Table 120. ExosomeDx Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. ExosomeDx Exosome Isolation Service Product Portfolio Table 122. ExosomeDx Recent Development Table 123. Irvine Scientific Company Information Table 124. Irvine Scientific Business Overview Table 125. Irvine Scientific Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Irvine Scientific Exosome Isolation Service Product Portfolio Table 127. Irvine Scientific Recent Development Table 128. Beckman Coulter Company Information Table 129. Beckman Coulter Business Overview Table 130. Beckman Coulter Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Beckman Coulter Exosome Isolation Service Product Portfolio Table 132. Beckman Coulter Recent Development Table 133. Stratech Company Information Table 134. Stratech Business Overview Table 135. Stratech Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Stratech Exosome Isolation Service Product Portfolio Table 137. Stratech Recent Development Table 138. QIAGEN Company Information Table 139. QIAGEN Business Overview Table 140. QIAGEN Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. QIAGEN Exosome Isolation Service Product Portfolio Table 142. QIAGEN Recent Development Table 143. Lifeasible Company Information Table 144. Lifeasible Business Overview Table 145. Lifeasible Exosome Isolation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Lifeasible Exosome Isolation Service Product Portfolio Table 147. Lifeasible Recent Development Table 148. North America Exosome Isolation Service Revenue by Type (2021-2026) & (US$ Million) Table 149. North America Exosome Isolation Service Revenue by Type (2027-2032) & (US$ Million) Table 150. North America Exosome Isolation Service Revenue by Application (2021-2026) & (US$ Million) Table 151. North America Exosome Isolation Service Revenue by Application (2027-2032) & (US$ Million) Table 152. North America Exosome Isolation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. North America Exosome Isolation Service Revenue by Country (2021-2026) & (US$ Million) Table 154. North America Exosome Isolation Service Revenue by Country (US$ Million) & (2027-2032) Table 155. Europe Exosome Isolation Service Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Exosome Isolation Service Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Exosome Isolation Service Revenue by Application (2021-2026) & (US$ Million) Table 158. Europe Exosome Isolation Service Revenue by Application (2027-2032) & (US$ Million) Table 159. Europe Exosome Isolation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Europe Exosome Isolation Service Revenue by Country (2021-2026) & (US$ Million) Table 161. Europe Exosome Isolation Service Revenue by Country (US$ Million) & (2027-2032) Table 162. China Exosome Isolation Service Revenue by Type (2021-2026) & (US$ Million) Table 163. China Exosome Isolation Service Revenue by Type (2027-2032) & (US$ Million) Table 164. China Exosome Isolation Service Revenue by Application (2021-2026) & (US$ Million) Table 165. China Exosome Isolation Service Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Exosome Isolation Service Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Exosome Isolation Service Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Exosome Isolation Service Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Exosome Isolation Service Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Exosome Isolation Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Exosome Isolation Service Revenue by Region (US$ Million) & (2021-2026) Table 172. Asia Exosome Isolation Service Revenue by Region (US$ Million) & (2027-2032) Table 173. SAMEA Exosome Isolation Service Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Exosome Isolation Service Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Exosome Isolation Service Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA Exosome Isolation Service Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA Exosome Isolation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Exosome Isolation Service Revenue by Country (2021-2026) & (US$ Million) Table 179. SAMEA Exosome Isolation Service Revenue by Country (US$ Million) & (2027-2032) Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Exosome Isolation Service Image Figure 2. Global Exosome Isolation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exosome Isolation Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ultracentrifugation Image Figure 5. Immunomagnetic Bead Method Image Figure 6. Size Exclusion Chromatography Image Figure 7. Global Exosome Isolation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Exosome Isolation Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Early Cancer Screening Image Figure 10. Neurological Disease Diagnosis Image Figure 11. Drug Delivery System Development Image Figure 12. Regenerative Medicine Image Figure 13. Other Image Figure 14. Global Exosome Isolation Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Exosome Isolation Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Exosome Isolation Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Exosome Isolation Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Exosome Isolation Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Exosome Isolation Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Exosome Isolation Service Revenue Market Share by Type (2021-2032) Figure 22. Global Exosome Isolation Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Exosome Isolation Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Exosome Isolation Service Revenue Market Share by Application (2021-2032) Figure 25. North America Exosome Isolation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Exosome Isolation Service Revenue Share by Type (2021-2032) Figure 27. North America Exosome Isolation Service Revenue Share by Application (2021-2032) Figure 28. North America Exosome Isolation Service Revenue Share by Country (2021-2032) Figure 29. United States Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Exosome Isolation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Exosome Isolation Service Revenue Share by Type (2021-2032) Figure 34. Europe Exosome Isolation Service Revenue Share by Application (2021-2032) Figure 35. Europe Exosome Isolation Service Revenue Share by Country (2021-2032) Figure 36. Germany Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Exosome Isolation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Exosome Isolation Service Revenue Share by Type (2021-2032) Figure 46. China Exosome Isolation Service Revenue Share by Application (2021-2032) Figure 47. Asia Exosome Isolation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Exosome Isolation Service Revenue Share by Type (2021-2032) Figure 49. Asia Exosome Isolation Service Revenue Share by Application (2021-2032) Figure 50. Asia Exosome Isolation Service Revenue Share by Region (2021-2032) Figure 51. Japan Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Exosome Isolation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Exosome Isolation Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Exosome Isolation Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Exosome Isolation Service Revenue Share by Country (2021-2032) Figure 61. Brazil Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Exosome Isolation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ultracentrifugation
  • Immunomagnetic Bead Method
  • Size Exclusion Chromatography
Applications
  • Early Cancer Screening
  • Neurological Disease Diagnosis
  • Drug Delivery System Development
  • Regenerative Medicine
  • Other
Companies covered
  • Codiak Biosciences
  • Aethlon Medical
  • NanoSomix
  • Aruna Bio
  • Creative Biostructure
  • AMSBIO
  • Everzom
  • System Biosciences
  • Creative Biolabs
  • Frontage Labs
  • Lonza
  • Capital Biosciences
  • Miltenyi Biotec
  • Novus Biologicals
  • Clara Biotech
  • Immunostep
  • ExosomeDx
  • Irvine Scientific
  • Beckman Coulter
  • Stratech
  • QIAGEN
  • Lifeasible

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Exosome Isolation Service Market by Type
  3. 1.2.1 Global Exosome Isolation Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ultracentrifugation
  5. 1.2.3 Immunomagnetic Bead Method
  6. 1.2.4 Size Exclusion Chromatography
  7. 1.3 Exosome Isolation Service Market by Application
  8. 1.3.1 Global Exosome Isolation Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Early Cancer Screening
  10. 1.3.3 Neurological Disease Diagnosis
  11. 1.3.4 Drug Delivery System Development
  12. 1.3.5 Regenerative Medicine
  13. 1.3.6 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Exosome Isolation Service Market Dynamics
  1. 2.1 Exosome Isolation Service Industry Trends
  2. 2.2 Exosome Isolation Service Industry Drivers
  3. 2.3 Exosome Isolation Service Industry Opportunities and Challenges
  4. 2.4 Exosome Isolation Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Exosome Isolation Service Market Perspective (2021-2032)
  2. 3.2 Global Exosome Isolation Service Growth Trends by Region
  3. 3.2.1 Global Exosome Isolation Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Exosome Isolation Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Exosome Isolation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Exosome Isolation Service Revenue by Players
  2. 4.1.1 Global Exosome Isolation Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Exosome Isolation Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Exosome Isolation Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Exosome Isolation Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Exosome Isolation Service Key Players Headquarters & Area Served
  7. 4.4 Global Exosome Isolation Service Players, Product Type & Application
  8. 4.5 Global Exosome Isolation Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Exosome Isolation Service Market CR5 and HHI
  11. 4.6.3 2025 Exosome Isolation Service Tier 1, Tier 2, and Tier 3
5 Exosome Isolation Service Market Size by Type
  1. 5.1 Global Exosome Isolation Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Exosome Isolation Service Revenue by Type (2021-2032)
  3. 5.3 Global Exosome Isolation Service Revenue Market Share by Type (2021-2032)
6 Exosome Isolation Service Market Size by Application
  1. 6.1 Global Exosome Isolation Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Exosome Isolation Service Revenue by Application (2021-2032)
  3. 6.3 Global Exosome Isolation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Codiak Biosciences
  2. 7.1.1 Codiak Biosciences Company Information
  3. 7.1.2 Codiak Biosciences Business Overview
  4. 7.1.3 Codiak Biosciences Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Codiak Biosciences Exosome Isolation Service Product Portfolio
  6. 7.1.5 Codiak Biosciences Recent Developments
  7. 7.2 Aethlon Medical
  8. 7.2.1 Aethlon Medical Company Information
  9. 7.2.2 Aethlon Medical Business Overview
  10. 7.2.3 Aethlon Medical Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Aethlon Medical Exosome Isolation Service Product Portfolio
  12. 7.2.5 Aethlon Medical Recent Developments
  13. 7.3 NanoSomix
  14. 7.3.1 NanoSomix Company Information
  15. 7.3.2 NanoSomix Business Overview
  16. 7.3.3 NanoSomix Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 NanoSomix Exosome Isolation Service Product Portfolio
  18. 7.3.5 NanoSomix Recent Developments
  19. 7.4 Aruna Bio
  20. 7.4.1 Aruna Bio Company Information
  21. 7.4.2 Aruna Bio Business Overview
  22. 7.4.3 Aruna Bio Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Aruna Bio Exosome Isolation Service Product Portfolio
  24. 7.4.5 Aruna Bio Recent Developments
  25. 7.5 Creative Biostructure
  26. 7.5.1 Creative Biostructure Company Information
  27. 7.5.2 Creative Biostructure Business Overview
  28. 7.5.3 Creative Biostructure Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biostructure Exosome Isolation Service Product Portfolio
  30. 7.5.5 Creative Biostructure Recent Developments
  31. 7.6 AMSBIO
  32. 7.6.1 AMSBIO Company Information
  33. 7.6.2 AMSBIO Business Overview
  34. 7.6.3 AMSBIO Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AMSBIO Exosome Isolation Service Product Portfolio
  36. 7.6.5 AMSBIO Recent Developments
  37. 7.7 Everzom
  38. 7.7.1 Everzom Company Information
  39. 7.7.2 Everzom Business Overview
  40. 7.7.3 Everzom Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Everzom Exosome Isolation Service Product Portfolio
  42. 7.7.5 Everzom Recent Developments
  43. 7.8 System Biosciences
  44. 7.8.1 System Biosciences Company Information
  45. 7.8.2 System Biosciences Business Overview
  46. 7.8.3 System Biosciences Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 System Biosciences Exosome Isolation Service Product Portfolio
  48. 7.8.5 System Biosciences Recent Developments
  49. 7.9 Creative Biolabs
  50. 7.9.1 Creative Biolabs Company Information
  51. 7.9.2 Creative Biolabs Business Overview
  52. 7.9.3 Creative Biolabs Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Creative Biolabs Exosome Isolation Service Product Portfolio
  54. 7.9.5 Creative Biolabs Recent Developments
  55. 7.10 Frontage Labs
  56. 7.10.1 Frontage Labs Company Information
  57. 7.10.2 Frontage Labs Business Overview
  58. 7.10.3 Frontage Labs Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Frontage Labs Exosome Isolation Service Product Portfolio
  60. 7.10.5 Frontage Labs Recent Developments
  61. 7.11 Lonza
  62. 7.11.1 Lonza Company Information
  63. 7.11.2 Lonza Business Overview
  64. 7.11.3 Lonza Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Lonza Exosome Isolation Service Product Portfolio
  66. 7.11.5 Lonza Recent Developments
  67. 7.12 Capital Biosciences
  68. 7.12.1 Capital Biosciences Company Information
  69. 7.12.2 Capital Biosciences Business Overview
  70. 7.12.3 Capital Biosciences Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Capital Biosciences Exosome Isolation Service Product Portfolio
  72. 7.12.5 Capital Biosciences Recent Developments
  73. 7.13 Miltenyi Biotec
  74. 7.13.1 Miltenyi Biotec Company Information
  75. 7.13.2 Miltenyi Biotec Business Overview
  76. 7.13.3 Miltenyi Biotec Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Miltenyi Biotec Exosome Isolation Service Product Portfolio
  78. 7.13.5 Miltenyi Biotec Recent Developments
  79. 7.14 Novus Biologicals
  80. 7.14.1 Novus Biologicals Company Information
  81. 7.14.2 Novus Biologicals Business Overview
  82. 7.14.3 Novus Biologicals Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Novus Biologicals Exosome Isolation Service Product Portfolio
  84. 7.14.5 Novus Biologicals Recent Developments
  85. 7.15 Clara Biotech
  86. 7.15.1 Clara Biotech Company Information
  87. 7.15.2 Clara Biotech Business Overview
  88. 7.15.3 Clara Biotech Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Clara Biotech Exosome Isolation Service Product Portfolio
  90. 7.15.5 Clara Biotech Recent Developments
  91. 7.16 Immunostep
  92. 7.16.1 Immunostep Company Information
  93. 7.16.2 Immunostep Business Overview
  94. 7.16.3 Immunostep Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Immunostep Exosome Isolation Service Product Portfolio
  96. 7.16.5 Immunostep Recent Developments
  97. 7.17 ExosomeDx
  98. 7.17.1 ExosomeDx Company Information
  99. 7.17.2 ExosomeDx Business Overview
  100. 7.17.3 ExosomeDx Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 ExosomeDx Exosome Isolation Service Product Portfolio
  102. 7.17.5 ExosomeDx Recent Developments
  103. 7.18 Irvine Scientific
  104. 7.18.1 Irvine Scientific Company Information
  105. 7.18.2 Irvine Scientific Business Overview
  106. 7.18.3 Irvine Scientific Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Irvine Scientific Exosome Isolation Service Product Portfolio
  108. 7.18.5 Irvine Scientific Recent Developments
  109. 7.19 Beckman Coulter
  110. 7.19.1 Beckman Coulter Company Information
  111. 7.19.2 Beckman Coulter Business Overview
  112. 7.19.3 Beckman Coulter Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Beckman Coulter Exosome Isolation Service Product Portfolio
  114. 7.19.5 Beckman Coulter Recent Developments
  115. 7.20 Stratech
  116. 7.20.1 Stratech Company Information
  117. 7.20.2 Stratech Business Overview
  118. 7.20.3 Stratech Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Stratech Exosome Isolation Service Product Portfolio
  120. 7.20.5 Stratech Recent Developments
  121. 7.21 QIAGEN
  122. 7.21.1 QIAGEN Company Information
  123. 7.21.2 QIAGEN Business Overview
  124. 7.21.3 QIAGEN Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 QIAGEN Exosome Isolation Service Product Portfolio
  126. 7.21.5 QIAGEN Recent Developments
  127. 7.22 Lifeasible
  128. 7.22.1 Lifeasible Company Information
  129. 7.22.2 Lifeasible Business Overview
  130. 7.22.3 Lifeasible Exosome Isolation Service Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Lifeasible Exosome Isolation Service Product Portfolio
  132. 7.22.5 Lifeasible Recent Developments
8 North America
  1. 8.1 North America Exosome Isolation Service Revenue (2021-2032)
  2. 8.2 North America Exosome Isolation Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Exosome Isolation Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Exosome Isolation Service Revenue by Type (2027-2032)
  5. 8.3 North America Exosome Isolation Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Exosome Isolation Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Exosome Isolation Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Exosome Isolation Service Revenue by Application (2027-2032)
  9. 8.5 North America Exosome Isolation Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Exosome Isolation Service Revenue by Country
  11. 8.6.1 North America Exosome Isolation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Exosome Isolation Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Exosome Isolation Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Exosome Isolation Service Revenue (2021-2032)
  2. 9.2 Europe Exosome Isolation Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Exosome Isolation Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Exosome Isolation Service Revenue by Type (2027-2032)
  5. 9.3 Europe Exosome Isolation Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Exosome Isolation Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Exosome Isolation Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Exosome Isolation Service Revenue by Application (2027-2032)
  9. 9.5 Europe Exosome Isolation Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Exosome Isolation Service Revenue by Country
  11. 9.6.1 Europe Exosome Isolation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Exosome Isolation Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Exosome Isolation Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Exosome Isolation Service Revenue (2021-2032)
  2. 10.2 China Exosome Isolation Service Revenue by Type (2021-2032)
  3. 10.2.1 China Exosome Isolation Service Revenue by Type (2021-2026)
  4. 10.2.2 China Exosome Isolation Service Revenue by Type (2027-2032)
  5. 10.3 China Exosome Isolation Service Revenue Share by Type (2021-2032)
  6. 10.4 China Exosome Isolation Service Revenue by Application (2021-2032)
  7. 10.4.1 China Exosome Isolation Service Revenue by Application (2021-2026)
  8. 10.4.2 China Exosome Isolation Service Revenue by Application (2027-2032)
  9. 10.5 China Exosome Isolation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Exosome Isolation Service Revenue (2021-2032)
  2. 11.2 Asia Exosome Isolation Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Exosome Isolation Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Exosome Isolation Service Revenue by Type (2027-2032)
  5. 11.3 Asia Exosome Isolation Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Exosome Isolation Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Exosome Isolation Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Exosome Isolation Service Revenue by Application (2027-2032)
  9. 11.5 Asia Exosome Isolation Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Exosome Isolation Service Revenue by Country
  11. 11.6.1 Asia Exosome Isolation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Exosome Isolation Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Exosome Isolation Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Exosome Isolation Service Revenue (2021-2032)
  2. 12.2 SAMEA Exosome Isolation Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Exosome Isolation Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Exosome Isolation Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Exosome Isolation Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Exosome Isolation Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Exosome Isolation Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Exosome Isolation Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Exosome Isolation Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Exosome Isolation Service Revenue by Country
  11. 12.6.1 SAMEA Exosome Isolation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Exosome Isolation Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Exosome Isolation Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst